InteRNA Technologies receives grant from Dutch government to develop miRNA-based therapeutics Nov. 17, 2010
AtheroNova and Cedars-Sinai Heart Institute partner on treatment to reduce arterial plaques Nov. 17, 2010
Isis and Xenon Pharma to develop hemojuvelin- and hepcidin-targeted drugs for anemia of inflammation Nov. 17, 2010
Resolve Therapeutics licenses agents for autoimmune disease from University of Washington Nov. 15, 2010
RSS